{
    "title": "112_hr6033",
    "content": "The Act titled \"Prostate Cancer Detection Research and Education Act\" aims to develop and validate tests for prostate cancer detection. The \"Prostate Cancer Detection Research and Education Act\" establishes an advisory council to draft a plan for accurate tests to detect prostate cancer, with members from various federal agencies. The advisory council established by the \"Prostate Cancer Detection Research and Education Act\" includes representatives from the National Cancer Institute, Department of Defense Congressionally Directed Medical Research Program, National Institute of Biomedical Imaging and Bioengineering, National Institute of General Medical Sciences, National Institute on Minority Health and Health Disparities, Office of the Director of the National Institutes of Health, and the Food and Drug Administration. The advisory council for the \"Prostate Cancer Detection Research and Education Act\" includes members from various federal agencies and 8 expert members from outside the Federal Government, including prostate cancer patient advocates, health care providers, and leading researchers. The advisory council for the \"Prostate Cancer Detection Research and Education Act\" consists of 8 expert members with prostate cancer-related expertise who meet quarterly to advise the Secretary and provide an annual report to Congress on federally funded research efforts for prostate cancer detection and diagnosis. The advisory council for the \"Prostate Cancer Detection Research and Education Act\" will develop a reliable test for prostate cancer detection and set standards for screening in coordination with the United States Preventive Services Task Force. The council will terminate on December 31, 2016, and the Secretary may allocate $1,000,000 annually from NIH funds for this purpose. The Director of the National Institutes of Health, in consultation with the Secretary of Defense, will coordinate and intensify research to develop a test for detecting and diagnosing prostate cancer. $30,000,000 may be allocated annually from NIH funds for this purpose. Additionally, a public awareness and education campaign will be implemented. The Secretary, along with the Directors of NIH and CDC, will conduct a national campaign to raise awareness about prostate cancer. The campaign will involve various organizations and the creation of educational materials and public service announcements to encourage men to seek screening for the disease. The Secretary will address racial disparities in prostate cancer incidences and mortality rates, as well as barriers to care for minorities. Grants will be awarded to test outreach strategies for increasing awareness of prostate cancer. Authorization of Appropriations: $5,000,000 is authorized for each fiscal year from 2013 to 2017 for this section."
}